Johnson & Johnson’s nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).
This article was originally published on MedicalXpress.com
FDA provides fast track designation to nipocalimab for systemic lupus erythematosus
You may also be interested in:
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
Twelve Foot Massage Techniques To Try Today
In this article, we will introduce you to 12 incredibly effective foot massage techniques that will leave you feeling rejuvenated and relaxed. Foot massages aren’t just a luxury; they provide numerous health benefits, such as […]
Read More:
-
Infants and toddlers with unilateral cerebral palsy, which affects the brain’s control of muscles on one side of the body, show lasting improvements in hand [...]
-
The World Health Organization (WHO) recommends that babies be exclusively breastfed for the first six months of life, since breastfeeding plays an important role in [...]
-
Feeding children ultra-processed foods, such as chicken nuggets, is common in the U.S. Social norms like this are difficult to change, but Rutgers Health researchers [...]
